MeVis Medical Solutions AG (M3V) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.005x

Based on the latest financial reports, MeVis Medical Solutions AG (M3V) has a cash flow conversion efficiency ratio of 0.005x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€96.63K ≈ $112.97K USD) by net assets (€17.83 Million ≈ $20.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MeVis Medical Solutions AG balance sheet quality to measure how much of total assets are equity-financed.

MeVis Medical Solutions AG - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how MeVis Medical Solutions AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check M3V cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

MeVis Medical Solutions AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MeVis Medical Solutions AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
OS Therapies Incorporated NYSE MKT:OSTX	-1.000x
Bever Holding NV AS:BEVER	-0.009x
JSS Real Estate SOCIMI SA MC:YJSS	0.002x
DESWELL INDS INC. DL-01 F:DW2	N/A
Oceanpal Inc NASDAQ:OP	-0.007x
Shuang-Bang Industrial TWO:6506	0.035x
Adaptimmune Therapeutics plc F:473A	0.490x
Minesto AB ST:MINEST	-0.057x

Annual Cash Flow Conversion Efficiency for MeVis Medical Solutions AG (2006–2025)

The table below shows the annual cash flow conversion efficiency of MeVis Medical Solutions AG from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see MeVis Medical Solutions AG (M3V) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-09-30	€17.83 Million ≈ $20.84 Million	€3.88 Million ≈ $4.54 Million	0.218x	+23.29%
2024-09-30	€17.83 Million ≈ $20.84 Million	€3.15 Million ≈ $3.68 Million	0.177x	-46.25%
2023-09-30	€17.83 Million ≈ $20.84 Million	€5.85 Million ≈ $6.84 Million	0.328x	+20.52%
2022-09-30	€17.83 Million ≈ $20.84 Million	€4.86 Million ≈ $5.68 Million	0.272x	-46.80%
2021-09-30	€17.83 Million ≈ $20.84 Million	€9.13 Million ≈ $10.68 Million	0.512x	+215.97%
2020-09-30	€17.83 Million ≈ $20.84 Million	€2.89 Million ≈ $3.38 Million	0.162x	-55.84%
2019-09-30	€17.83 Million ≈ $20.84 Million	€6.54 Million ≈ $7.65 Million	0.367x	+113.19%
2018-09-30	€32.06 Million ≈ $37.48 Million	€5.52 Million ≈ $6.45 Million	0.172x	-23.55%
2017-09-30	€32.51 Million ≈ $38.01 Million	€7.32 Million ≈ $8.56 Million	0.225x	+111.15%
2016-09-30	€32.89 Million ≈ $38.45 Million	€3.51 Million ≈ $4.10 Million	0.107x	-45.32%
2015-09-30	€33.73 Million ≈ $39.43 Million	€6.58 Million ≈ $7.69 Million	0.195x	+22.25%
2014-09-30	€30.27 Million ≈ $35.39 Million	€4.83 Million ≈ $5.65 Million	0.160x	-43.60%
2013-09-30	€26.45 Million ≈ $30.92 Million	€7.48 Million ≈ $8.75 Million	0.283x	+21.84%
2012-09-30	€22.77 Million ≈ $26.62 Million	€5.29 Million ≈ $6.18 Million	0.232x	-5.73%
2011-09-30	€20.73 Million ≈ $24.23 Million	€5.11 Million ≈ $5.97 Million	0.246x	+23.38%
2010-09-30	€24.79 Million ≈ $28.98 Million	€4.95 Million ≈ $5.79 Million	0.200x	+112.02%
2009-09-30	€32.61 Million ≈ $38.12 Million	€3.07 Million ≈ $3.59 Million	0.094x	+5.62%
2008-09-30	€32.61 Million ≈ $38.13 Million	€2.91 Million ≈ $3.40 Million	0.089x	+211.17%
2007-09-30	€30.77 Million ≈ $35.97 Million	€-2.47 Million ≈ $-2.89 Million	-0.080x	-104.63%
2006-09-30	€2.65 Million ≈ $3.10 Million	€4.59 Million ≈ $5.37 Million	1.732x	--

About MeVis Medical Solutions AG

XETRA:M3V Germany Health Information Services

Market Cap

$50.22 Million

€42.95 Million EUR

Market Cap Rank

#22422 Global

#1981 in Germany

Share Price

€23.60

Change (1 day)

+0.85%

52-Week Range

€22.20 - €26.40

All Time High

€35.79